Company News

December 19^th, 2008, CapitalBio Corporation announced that Professor Jing Cheng, the Director of NERCBBT (National Engineering Research Center for Beijing Biochip Technology) and the CTO of CapitalBio Corporation was awarded the “2008 Tanjiazhen Life Science Innovation Award” for his outstanding contribution to the field of biochip development in China.

October 29^th, 2008, Professor Jing Cheng, the Director of NERCBBT (National Engineering Research Center for Beijing Biochip Technology) and the CTO of CapitalBio Corporation has been awarded the "2008 HOLEUNG HO LEE Prize for Youth Innovation" for his outstanding contribution to the development of Biochip Technology in China. 

OCTOBER 15, 2008, CapitalBio Corporation, a leading Chinese life science company which develops and markets biochip technologies, tools and services and VigeneTech Inc. which develops image analysis solutions for bioscience research, announced a strategic partnership to create integrated hardware-software solutions for protein array analysis. Customized OEM software made from VigeneTech will be integrated with CapitalBio LuxScan microarray scanners to provide fully integrated and personalized solutions.

Beijing, China & Cape Town, RSA (September 09, 2008) — The Centre for Proteomic & Genomic Research (CPGR), a South African Government sponsored, not for profit, core technology facility in Cape Town, South Africa, and CapitalBio (CB), a leading biotech company in Beijing, China, announce that they are entering into a mutual agreement in the field of Genomic Medicine and Biomarker Discovery.

The international immuno-diagnostics companies Phadia (Uppsala, Sweden) and VBC-Genomics (Vienna, Austria) announce the formation of a business alliance with biochip and microarray instrumentation developer and manufacturer CapitalBio (Beijing, China).  The companies issued a joint statement on 5th September 2008 to announce a major advance in the provision of high throughput allergy testing with their ImmunoCAP ISAC arrays and analysing the result with CapitalBio´s new LuxScan dual laser scanners.
 

September 5th, 2008, Beijing – The National Engineering Research Center for Beijing Biochip Technology (NERCBBT) announced that it had received the approval from the Standardization Administration of the People´s Republic of China (SAC) for the foundation of the National Technical Committee 421 on Biochip of Standardization Administration of China, serial number SAC/TC 421.

23 May 2008, Beijing –The National Engineering Research Center for Beijing Biochip Technology (NERCBBT) (CapitalBio Corporation), Beijing announced that Professor Jing Cheng and his research team at Tsinghua University and the NERCBBT created a lab-on-a-chip style cell monitoring device which can mimic wounding processes and wound recovery processes.  The device creates artificial wounds and then continuously monitors the migration of surrounding cells as they move to heal the wound. This exciting research has been published as the cover story in the June issue of Lab on a Chip, the top scientific journal for global biochip research.

January 7th, 2008, Beijing China -- CapitalBio Corporation announced that one of its patents, A Micro-Volume Liquid Ejection System (Inventors: Dong Wang, Kun Zou, Jianxin Ye, Yelei Sun, Hui Zhu, Xianhua Wang, Jing Cheng. Patent NO.: ZL200410086248.0), had won the 10th China Patent Award from State Intellectual Property Office of P.R. China (SIPO).

China Patent Award, established by SIPO in 1989, is the only government patent award given every two years and has been approved by World Intellectual Property Office (WIPO).

January 8th, 2008, Beijing – CapitalBio Corporation announced that it received the second place of Technology Invention Award of 2007 State Scientific & Technological Award for its prestigious project titled "Development and Applications of Systematic Biochips and Related Equipment". This project was led by Dr. Jing Cheng, Chief Technology Officer of CapitalBio Corporation. 

January 23,2008,Beijing - Capitalbio Corporation Announced that its Bioassay Laboratory has received the Laboratory Accreditation Certificate (Registration No.:CNAS L2451) from China National Accreditation Service for Conformity Assessment (CNAS).

CNAS is the national accreditation body of China responsible for the accreditation and certification of  laboratories and inspections. CNAS was established under the approval of the Certification and Accreditation Administration of the People´s Republic of China in accordance with the Regulations on Certification and Accreditation.